Premium
Levetiracetam‐induced pediatric toxic epidermal necrolysis successfully treated with etanercept
Author(s) -
Estébanez Andrea,
SáezMartín Luis Carlos,
Muñoz Juan Ignacio,
Silva Esmeralda,
Monrabal Alicia,
Monteagudo Carlos,
Ramón María Dolores
Publication year - 2020
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.14179
Subject(s) - etanercept , medicine , toxic epidermal necrolysis , levetiracetam , dermatology , infliximab , tumor necrosis factor alpha , surgery , epilepsy , psychiatry
Successful management of toxic epidermal necrolysis (TEN) with tumor necrosis factor‐α inhibitors has been described in adults, but few cases have been reported in children. To date, only four pediatric cases of TEN treated with infliximab and one with etanercept have been published. We present the case of an 8‐year‐old boy diagnosed with TEN induced by levetiracetam, successfully treated with etanercept, systemic corticosteroids, and intravenous immunoglobulin.